Forte Biosciences, Inc. (FBRX) Stock Analysis & Investment Frameworks
Forte Biosciences, Inc. (FBRX) stock analysis on Invetso. Review Forte Biosciences, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Forte Biosciences, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Forte Biosciences, Inc. Key Financial Metrics
- Market Cap: $1.63B
- Revenue: $N/A
- ROE: -94.82%
- ROIC: -48.53%
- Dividend Yield: N/A
About Forte Biosciences, Inc.
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.